ImageneBio, Inc.

IMA ·Healthcare, Drug Manufacturers - General, United States
Balance Sheet Asset & Liabilities Breakdown

Asset & Liabilities Breakdown

Asset Breakdown FY2021

Total Assets: $247.9M

Liabilities Breakdown FY2021

Total Liabilities: $40.0M